Dr. Reddy's Laboratories today announced the acquisition of an eminent portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories.

The company acquired six OTC brands from Ducere Pharma, including Doan's, Bufferin, Nupercainal ointment, Cruex Nail gel, Comtrev, and Myoflex.

"These legacy products enjoy strong brand equity built over several decades," said Alok Sonig, executive vice president and head of Dr. Reddy's in the US. "We are extremely excited to be entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US."

Shares of the company gained Rs 40.05, or 1.32%, to trade at Rs 3,065.30. The total volume of shares traded was 22,385 at the BSE (2.59 p.m., Wednesday).